Dimensional Fund Advisors
NRIX icon

Dimensional Fund Advisors’s Nurix Therapeutics NRIX Stock Holding History

Dimensional Fund Advisors’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7M Buy
1,431,317
+650,621
+83% +$11.1M 0.01% 1788
2026
Q1 		$12.1M Buy
780,696
+349,710
+81% +$5.8M ﹤0.01% 2188
2025
Q4 		$8.18M Buy
430,986
+24
+0% +$345 ﹤0.01% 2354
2025
Q3 		$3.98M Buy
430,962
+3,891
+0.9% +$40.4K ﹤0.01% 2604
2025
Q2 		$4.87M Sell
427,071
-148,241
-26% -$1.6M ﹤0.01% 2531
2025
Q1 		$6.84M Buy
575,312
+68,473
+14% +$1.15M ﹤0.01% 2399
2024
Q4 		$9.55M Buy
506,839
+5,270
+1% +$121K ﹤0.01% 2326
2024
Q3 		$11.3M Sell
501,569
-101,564
-17% -$2.3M ﹤0.01% 2251
2024
Q2 		$12.6M Sell
603,133
-363,320
-38% -$5.66M ﹤0.01% 2158
2024
Q1 		$14.2M Sell
966,453
-33,591
-3% -$361K ﹤0.01% 2159
2023
Q4 		$10.3M Buy
1,000,044
+42,001
+4% +$288K ﹤0.01% 2308
2023
Q3 		$7.53M Buy
958,043
+180,531
+23% +$1.65M ﹤0.01% 2383
2023
Q2 		$7.77M Buy
777,512
+143,995
+23% +$1.47M ﹤0.01% 2366
2023
Q1 		$5.63M Buy
+633,517
New +$6.6M ﹤0.01% 2448
2022
Q3 		$4.36M Buy
334,725
+130,423
+64% +$2.06M ﹤0.01% 2474
2022
Q2 		$2.59M Sell
204,302
-33,223
-14% -$377K ﹤0.01% 2662
2022
Q1 		$3.33M Buy
237,525
+121,167
+104% +$2.15M ﹤0.01% 2666
2021
Q4 		$3.37M Buy
+116,358
New +$3.53M ﹤0.01% 2694

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's NRIX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Nurix Therapeutics (NRIX) stake by 83% in Q2 2026, buying an estimated $11.1M and bringing the position to 1,431,317 shares worth $34.7M. The position accounts for 0.01% of the portfolio, ranked #1788.

Dimensional Fund Advisors first reported a position in NRIX in Q4 2021 and has held it in 18 quarters since. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Dimensional Fund Advisors held 1,431,317 shares of Nurix Therapeutics worth $34.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 650,621 Nurix Therapeutics shares in Q2 2026, an estimated $11.1M.
  • Nurix Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1788 holding.
  • Dimensional Fund Advisors first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.